These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18938028)

  • 21. High frequency of p16 promoter methylation in non-small cell lung carcinomas from Chile.
    Guzman LM; Koriyama C; Akiba S; Eizuru Y; Castillo D; Corvalan A; Aguayo FR
    Biol Res; 2007; 40(3):365-72. PubMed ID: 18449464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.
    Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS
    Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Influence of nicotine addiction on telomerase activity in malignant non-small cell lung tumors].
    Targowski T; Jahnz-Rózyk K; Szkoda T; From S; Rozyńska R; Płusa T
    Przegl Lek; 2005; 62(10):1043-6. PubMed ID: 16521949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas.
    Richmond-Sinclair NM; Lee E; Cummings MC; Williamson R; Muller K; Green AC; Hayward NK; Whiteman DC
    Melanoma Res; 2008 Oct; 18(5):336-45. PubMed ID: 18781132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of P16INK4A and retinoblastoma proteins in non-small-cell lung carcinoma.
    Akin H; Yilmazbayhan D; Kiliçaslan Z; Dilege S; Doğan O; Toker A; Kalayci G
    Lung Cancer; 2002 Dec; 38(3):253-60. PubMed ID: 12445746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of the retinoblastoma and p16 pathway correlate with promoter methylation in malignant fibrous histiocytomas.
    Brinck U; Schlott T; Störber S; Stachura J; Bortkiewicz P; Nagel WD; Hasse FM; Cordon-Cardo C; Fischer G; Korabiowska M
    Anticancer Res; 2006; 26(5A):3461-5. PubMed ID: 17094467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.
    Karim RZ; Li W; Sanki A; Colman MH; Yang YH; Thompson JF; Scolyer RA
    Int J Surg Pathol; 2009 Oct; 17(5):361-7. PubMed ID: 19666944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of WWOX protein and its significance in non-small cell lung cancers].
    Zhou YL; Xu YJ; Zhang ZX
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):297. PubMed ID: 17760259
    [No Abstract]   [Full Text] [Related]  

  • 32. Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer.
    Hsu NY; Cheng YW; Chan IP; Ho HC; Chen CY; Hsu CP; Lin MH; Chou MC
    Oncol Rep; 2009 Jan; 21(1):81-7. PubMed ID: 19082446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different susceptibility of increased DNMT1 expression by exposure to tobacco smoke according to histology in primary non-small cell lung cancer.
    Kwon YM; Park JH; Kim H; Shim YM; Kim J; Han J; Park J; Kim DH
    J Cancer Res Clin Oncol; 2007 Apr; 133(4):219-26. PubMed ID: 17053888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy.
    Ceppi P; Novello S; Cambieri A; Longo M; Monica V; Lo Iacono M; Giaj-Levra M; Saviozzi S; Volante M; Papotti M; Scagliotti G
    Clin Cancer Res; 2009 Feb; 15(3):1039-45. PubMed ID: 19188177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Environmental tobacco smoke and lung cancer among Chinese nonsmoking males: might adenocarcinoma be the culprit?
    Tse LA; Yu IT; Au JS; Yu KS; Kwok KP; Qiu H; Wong TW
    Am J Epidemiol; 2009 Mar; 169(5):533-41. PubMed ID: 19126588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
    Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metallic elements in pulmonary biopsies from lung cancer and control subjects.
    De Palma G; Goldoni M; Catalani S; Carbognani P; Poli D; Mozzoni P; Acampa O; Internullo E; Rusca M; Apostoli P
    Acta Biomed; 2008; 79 Suppl 1():43-51. PubMed ID: 18924309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
    Zhu ZH; Sun BY; Ma Y; Shao JY; Long H; Zhang X; Fu JH; Zhang LJ; Su XD; Wu QL; Ling P; Chen M; Xie ZM; Hu Y; Rong TH
    J Clin Oncol; 2009 Mar; 27(7):1091-9. PubMed ID: 19188679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
    Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.